echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > When the vaccine comes, the public will be able to get it fully

    When the vaccine comes, the public will be able to get it fully

    • Last Update: 2020-12-22
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The State Council joint prevention and control mechanism held a press conference on the 19th, the State Council joint prevention and control mechanism scientific research and development team head of the vaccine research and development team, deputy director of the National Health and Health Commission Zeng Yixin introduced, at present, China's overall situation of epidemic prevention and control is good, but the "foreign defense input, internal defense rebound" pressure is still very large. In the winter and spring festival, some key groups of people to carry out new coronavirus vaccination work, follow-up efforts to achieve high-risk population "should be followed up."Zheng Zhongwei, head of the special working group on vaccine research and development of the joint prevention and control mechanism of the State Council and director of the National Health and Health Commission's Medical and Health Science and Technology Development Research Center, said that after the outbreak, China laid out five technical routes to promote vaccine research and development. At present, according to the Statistics of the World Health Organization, China's vaccine into clinical trials and into the third phase of clinical vaccines, are in the world's first square.
    countries and regions that cooperate in Phase III clinical trials in China are not, or are not, the countries and regions with the highest outbreaks in the world at present, so the rate of obtaining phase III clinically required cases is not the fastest. At present, China's relatively fast-moving vaccine has obtained the number of cases needed in the middle of Phase III clinical trials, and has recently provided relevant materials to the State Drug Administration. If the data meet the corresponding standards, the State Drug Administration will approve conditional listing or listing, China's vaccine will be more widely available, faster increase in production, China is ready for large-scale production." key population vaccination has immunity, it is equivalent to more people in daily production, living places to build a barrier first. Cui Gang, head of the CDC of the National Health and Health Commission, said.
    china's current vaccination strategy is in accordance with the "two-step" program, the implementation of vaccination throughout the country.
    The first step is mainly to vaccinate some key population groups, including those who are engaged in import cold chain, port quarantine, ship piloting, air traffic, fresh market, public transportation, medical disease control and other high-risk infection risk staff, as well as people who go to high-risk countries or regions to work or study, try to alleviate the pressure of imported outbreak prevention and control, reduce the risk of local cases and domestic outbreaks.
    second step, as vaccine conditions are approved for market or formally approved for market, vaccine production will gradually increase and more vaccines will be put into use. Through orderly vaccination, eligible people can achieve "catch-up".
    The Joint Prevention and Control Mechanism of the State Council has issued a circular to member units, provinces, districts and cities and Xinjiang Production and Construction Corps, requiring relevant departments and units to effectively pass the quality of vaccines, each batch of vaccines must go through rigorous testing, to ensure that the cold chain transport safe and smooth, timely and accurate distribution. Under the premise of informed consent, strengthen citizens' awareness of their obligations and responsibilities to vaccinate, and strive to achieve a high-risk population "should be met", all eligible people can be vaccinated on time.
    Zeng Yixin said that China's vaccination, not only to protect the Chinese people, but also for the global epidemic prevention and control to make a Contribution to China. According to the vaccine market approval, according to the vaccine production and supply capacity, China will gradually upgrade, gradually promote, and gradually popularize.
    , vaccination units are located in health service centers, township hospitals or general hospitals in the district, and information on vaccination services will be published in a timely manner. "Other people who haven't been vaccinated for the time being don't have to worry." Cui gang said that personal protection, wearing masks in public places, keeping social distance, washing hands, etc. , these measures have proved very effective., China has officially launched emergency vaccinations for high-risk exposed populations. On the premise of voluntary, informed and consensual, more than 1 million doses of emergency vaccination have been completed. After strict adverse reaction monitoring and follow-up observation, no serious adverse reactions appeared.
    Junfeng, head of the Consumer Goods Industry Department of the Ministry of Industry and Information Technology, said that China promotes enterprises to speed up the process of industrialization and make full preparations for the large-scale production of vaccines.
    Wang Huaqing, chief expert and chief physician of the CDC's immunization program, said the CDC has established a monitoring system involving abnormal vaccine responses and will analyze and assess vaccination risks in a timely manner if important events occur. There are hundreds of thousands of genes sequencing that are currently shared around the world, and no major mutations in the new coronavirus have been found.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.